Lisa M. Giles's Net Worth
$2.04 Million
Who is Lisa M. Giles?
Lisa M. Giles has an estimated net worth of $2.04 Million. This is based on reported shares across multiple companies, which include GenMark Diagnostics, Inc., Milestone Pharmaceuticals Inc., HCW Biologics Inc., and Durata Therapeutics, Inc..
SEC CIK
Lisa M. Giles's CIK is 0001568850
Past Insider Trading and Trends
2015 was Lisa M. Giles's most active year for acquiring shares with 4 total transactions. Lisa M. Giles's most active month to acquire stocks was the month of April. 2014 was Lisa M. Giles's most active year for disposing of shares, totalling 5 transactions. Lisa M. Giles's most active month to dispose stocks was the month of October. 2015 saw Lisa M. Giles paying a total of $26,400.00 for 31,275 shares, this is the most they've acquired in one year. In 2021 Lisa M. Giles cashed out on 106,134 shares for a total of $2,094,081.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GenMark Diagnostics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -87.07K |
$24.05 | -$2,094,081.60 |
0
|
Apr 22
| |||
Form 4
| +10.55% | 7.78K |
—
|
—
| 81.57K |
Feb 18
| |||
Form 4
| +23.06% | 13.82K |
—
|
—
| 73.79K |
May 29
| |||
Form 4
| +0.89% | 528 |
—
|
—
| 59.97K |
Oct 30
| |||
Form 4
| +1.20% | 702 |
—
|
—
| 59.44K |
Jul 31
| |||
Form 4
| +43.97% | 17.94K |
—
|
—
| 58.73K |
May 31
| |||
Form 4
| +72.21% | 17.11K |
—
|
—
| 40.8K |
May 24
| |||
Form 4
| +41.78% | 6.98K |
—
|
—
| 23.69K |
May 25
| |||
Form 4/A
| +3.33% | 177 |
$9.40 | $1,663.80 | 5.5K |
Aug 12
| |||
Form 4
| +18.29% | 823 |
$9.40 | $7,736.20 | 5.32K |
Aug 12
| |||
Form 4
| +103.46% | 8.5K |
—
|
—
| 16.71K |
May 26
| |||
Form 4
| +800.00% | 4K |
$6.60 | $26,400.00 | 4.5K |
Nov 3
| |||
Form 4
| +374.74% | 6.48K |
—
|
—
| 8.21K |
May 28
| |||
Form 4
|
∞
| 1.73K |
—
|
—
| 1.73K |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.525
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HCW Biologics Inc. (HCWB) Snapshot price: $1.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +35,715.00% | 35.72K |
$1.40 | $50,001.00 | 35.81K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Durata Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.50K |
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +50.00% | 500 |
$8.25 | $4,125.00 | 1.5K |
Aug 6
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 1K |
$10.95 | $10,950.00 | 1K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||